A61K 9/122
Foams
Official title: {Foams; Dry foams (edible foams A61K9/0056)}
A61K9/122 (Foams) appears on 473 US grants and 807 published applications in this corpus.
Search patents in A61K- Granted patents
- 473
- Published applications
- 807
- Assignees
- 332
- Inventors
- 957
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 5 | 0 |
| 1993 | 1 | 0 |
| 1994 | 4 | 0 |
| 1995 | 4 | 0 |
| 1996 | 0 | 0 |
| 1997 | 8 | 0 |
| 1998 | 5 | 0 |
| 1999 | 8 | 0 |
| 2000 | 6 | 0 |
| 2001 | 4 | 2 |
| 2002 | 4 | 14 |
| 2003 | 6 | 14 |
| 2004 | 7 | 19 |
| 2005 | 7 | 24 |
| 2006 | 12 | 25 |
| 2007 | 2 | 31 |
| 2008 | 5 | 35 |
| 2009 | 4 | 25 |
| 2010 | 11 | 32 |
| 2011 | 7 | 29 |
| 2012 | 16 | 26 |
| 2013 | 19 | 42 |
| 2014 | 28 | 42 |
| 2015 | 24 | 26 |
| 2016 | 21 | 27 |
| 2017 | 32 | 50 |
| 2018 | 24 | 40 |
| 2019 | 26 | 64 |
| 2020 | 42 | 50 |
| 2021 | 27 | 44 |
| 2022 | 22 | 29 |
| 2023 | 15 | 40 |
| 2024 | 22 | 25 |
| 2025 | 18 | 34 |
| 2026 | 12 | 18 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Method for reducing side effects from administration of phosphodiesterase-4 inhibitors4 Aug 2026US 12,697,329 B2Arcutis Biotherapeutics, Inc.
- Therapeutic carbon monoxide formulations28 Jul 2026US 12,691,140 B2Beth Israel Deaconess Medical Center, Inc.
- Method for reducing side effects from administration of phosphodiesterase-4 inhibitors21 Jul 2026US 12,685,727 B2Arcutis Biotherapeutics, Inc.
- Compositions, gels and foams with rheology modulators and uses thereof23 Jun 2026US 12,661,407 B2Journey Medical Corporation
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions26 May 2026US 12,636,308 B2Adora Animal Health Corporation
- Cartridge for Housing a Production of a Therapeutic Microfoam, Automated Device, Method for Producing a Therapeutic Microfoam, and Microfoam24 Sep 2026US 2026/0283952 A1
- Recombinant protein compositions useful for wound healing10 Sep 2026US 2026/0263559 A1Wake Forest University Health Sciences
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions20 Aug 2026US 2026/0240898 A1Adora Life Science, Inc.
- Foam for pulmonary drug delivery13 Aug 2026US 2026/0232580 A1Technion Research & Development Foundation Limited
- Storage stable formulations of sulfated glycosaminoglycans and fragments derived therefrom for the treatment of pain and other medical conditions13 Aug 2026US 2026/0232722 A1Adora Life Science, Inc.
Most cited
By later US patents
- Foam substrate and micropackaged active ingredient particle composite dispensing materials1,078US 4,828,542 ATwin Rivers Engineering · 1989
- Mesocellular oxide foams as hemostatic compositions and methods of use1,075US 8,202,549 B2The Regents of the University of California · 2012
- Antigen-adjuvant compositions and methods1,024US 8,790,658 B2Sanofi Pasteur Limited · 2014
- Dermal penetration enhancers and drug delivery systems involving same297US 6,299,900 B1Monash University · 2001
- Super absorbent hydrogel foams211US 5,750,585 APurdue Research Foundation · 1998